Seasonal Influenza Vaccination Clinical Trial
Official title:
Seasonal Influenza Vaccination Reminders for Children With High-risk Conditions
Verified date | September 2011 |
Source | University of Michigan |
Contact | n/a |
Is FDA regulated | No |
Health authority | United States: Institutional Review Board |
Study type | Interventional |
The objective of this study was to assess the feasibility and effectiveness of using a statewide immunization information system (IIS) to send seasonal influenza vaccine reminders from Local Health Departments (LHDs), targeting children with high-risk conditions.
Status | Completed |
Enrollment | 3618 |
Est. completion date | December 2010 |
Est. primary completion date | February 2009 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 24 Months to 60 Months |
Eligibility |
Inclusion Criteria: - children, 24-60 months - current or previous enrollment in Medicaid (Michigan) - presence of at least 1 chronic condition, as indicated by the Michigan Care Improvement Registry (MCIR) - resident of Kalamazoo, Ottawa, or Kent counties (Michigan) Exclusion Criteria: - receipt of influenza prior to notification date - ineligible for reminder/recall notification in the Michigan Care Improvement Registry (MCIR) |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Health Services Research
Country | Name | City | State |
---|---|---|---|
United States | University of Michigan, Child Health Evaluation and Research Unit | Ann Arbor | Michigan |
Lead Sponsor | Collaborator |
---|---|
University of Michigan | Centers for Disease Control and Prevention |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | seasonal influenza vaccination | Receipt of 1 or more dose of seasonal influenza vaccine, either trivalent inactivated influenza vaccine (TIV) or live attenuated influenza vaccine (LAIV) | up to 4 months following reminder notification | No |
Secondary | invalid mailing address | Postal mailing address determined to be invalid for mail delivery, either by physical return of mailed reminder notification, or through the United States Postal Service's National Change of Address (NCOA) process | up to 4 months following reminder notification | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT05129436 -
Adaptive Immune Response to Seasonal Influenza Vaccination (AIGI)
|